Exploring intra- and inter-reader variability in uni-dimensional, bi-dimensional, and volumetric measurements of solid tumors on CT scans reconstructed at different slice intervals
Zhao, Binsheng, Tan, Yongqiang, Bell, Daniel J, Marley, Sarah E, Guo, Pingzhen, Mann, Helen, Scott, Marietta L.J, Schwartz, Lawrence H, Ghiorghiu, Dana C
Published in European journal of radiology (01.06.2013)
Published in European journal of radiology (01.06.2013)
Get full text
Journal Article
Safety, tolerability, pharmacokinetics, and antitumor activity of adavosertib in Japanese patients with advanced solid tumors: A phase I, open-label study
Kondo, Shunsuke, Katsuya, Yuki, Yonemori, Kan, Komuro, Keiko, Sugeno, Masatoshi, Kawata, Toshio, Ghiorghiu, Dana, Meulendijks, Didier, Yamamoto, Noboru
Published in Cancer treatment and research communications (2024)
Published in Cancer treatment and research communications (2024)
Get full text
Journal Article
Enhancing Fraction Predicts Clinical Outcome following First-Line Chemotherapy in Patients with Epithelial Ovarian Carcinoma
O'CONNOR, James P. B, JAYSON, Gordon C, PARKER, Geoffrey J. M, JACKSON, Alan, GHIORGHIU, Dana, CARRINGTON, Bernadette M, ROSE, Chris J, MILLS, Samantha J, SWINDELL, Ric, ROBERTS, Caleb, MITCHELL, Claire L
Published in Clinical cancer research (15.10.2007)
Published in Clinical cancer research (15.10.2007)
Get full text
Journal Article
CNS Efficacy of Osimertinib in Patients With T790M-Positive Advanced Non-Small-Cell Lung Cancer: Data From a Randomized Phase III Trial (AURA3)
Wu, Yi-Long, Ahn, Myung-Ju, Garassino, Marina Chiara, Han, Ji-Youn, Katakami, Nobuyuki, Kim, Hye Ryun, Hodge, Rachel, Kaur, Paramjit, Brown, Andrew P, Ghiorghiu, Dana, Papadimitrakopoulou, Vassiliki A, Mok, Tony S K
Published in Journal of clinical oncology (10.09.2018)
Published in Journal of clinical oncology (10.09.2018)
Get full text
Journal Article
Selumetinib Plus Docetaxel Compared With Docetaxel Alone and Progression-Free Survival in Patients With KRAS-Mutant Advanced Non–Small Cell Lung Cancer: The SELECT-1 Randomized Clinical Trial
Jänne, Pasi A, van den Heuvel, Michel M, Barlesi, Fabrice, Cobo, Manuel, Mazieres, Julien, Crinò, Lucio, Orlov, Sergey, Blackhall, Fiona, Wolf, Juergen, Garrido, Pilar, Poltoratskiy, Artem, Mariani, Gabriella, Ghiorghiu, Dana, Kilgour, Elaine, Smith, Paul, Kohlmann, Alexander, Carlile, David J, Lawrence, David, Bowen, Karin, Vansteenkiste, Johan
Published in JAMA : the journal of the American Medical Association (09.05.2017)
Published in JAMA : the journal of the American Medical Association (09.05.2017)
Get full text
Journal Article
Osimertinib with or without Chemotherapy in EGFR -Mutated Advanced NSCLC
Planchard, David, Jänne, Pasi A, Cheng, Ying, Yang, James C-H, Yanagitani, Noriko, Kim, Sang-We, Sugawara, Shunichi, Yu, Yan, Fan, Yun, Geater, Sarayut L, Laktionov, Konstantin, Lee, Chee K, Valdiviezo, Natalia, Ahmed, Samreen, Maurel, Jean-Marc, Andrasina, Igor, Goldman, Jonathan, Ghiorghiu, Dana, Rukazenkov, Yuri, Todd, Alex, Kobayashi, Kunihiko
Published in The New England journal of medicine (23.11.2023)
Published in The New England journal of medicine (23.11.2023)
Get full text
Journal Article
Population Pharmacokinetic Modeling of Adavosertib (AZD1775) in Patients with Solid Tumors
Johnson, Martin, Kaschek, Daniel, Ghiorghiu, Dana, Lanke, Shankar, Miah, Kowser, Schmidt, Henning, Mugundu, Ganesh M
Published in Journal of clinical pharmacology (01.11.2024)
Published in Journal of clinical pharmacology (01.11.2024)
Get more information
Journal Article
Selumetinib in Combination With Dacarbazine in Patients With Metastatic Uveal Melanoma: A Phase III, Multicenter, Randomized Trial (SUMIT)
Carvajal, Richard D, Piperno-Neumann, Sophie, Kapiteijn, Ellen, Chapman, Paul B, Frank, Stephen, Joshua, Anthony M, Piulats, Josep M, Wolter, Pascal, Cocquyt, Veronique, Chmielowski, Bartosz, Evans, T R Jeffry, Gastaud, Lauris, Linette, Gerald, Berking, Carola, Schachter, Jacob, Rodrigues, Manuel J, Shoushtari, Alexander N, Clemett, Delyth, Ghiorghiu, Dana, Mariani, Gabriella, Spratt, Shirley, Lovick, Susan, Barker, Peter, Kilgour, Elaine, Lai, Zhongwu, Schwartz, Gary K, Nathan, Paul
Published in Journal of clinical oncology (20.04.2018)
Published in Journal of clinical oncology (20.04.2018)
Get full text
Journal Article
Osimertinib after Chemoradiotherapy in Stage III EGFR -Mutated NSCLC
Lu, Shun, Kato, Terufumi, Dong, Xiaorong, Ahn, Myung-Ju, Quang, Le-Van, Soparattanapaisarn, Nopadol, Inoue, Takako, Wang, Chih-Liang, Huang, Meijuan, Yang, James Chih-Hsin, Cobo, Manuel, Özgüroğlu, Mustafa, Casarini, Ignacio, Khiem, Dang-Van, Sriuranpong, Virote, Cronemberger, Eduardo, Takahashi, Toshiaki, Runglodvatana, Yotsawaj, Chen, Ming, Huang, Xiangning, Grainger, Ellie, Ghiorghiu, Dana, van der Gronde, Toon, Ramalingam, Suresh S
Published in The New England journal of medicine (15.08.2024)
Published in The New England journal of medicine (15.08.2024)
Get more information
Journal Article
Real-world outcomes in patients with advanced endometrial cancer: A retrospective cohort study of US electronic health records
Monk, Bradley J., Smith, Gabriella, Lima, Julianne, Long, Gráinne H., Alam, Naufil, Nakamura, Hitomi, Meulendijks, Didier, Ghiorghiu, Dana, Banerjee, Susana
Published in Gynecologic oncology (01.02.2022)
Published in Gynecologic oncology (01.02.2022)
Get full text
Journal Article
CNS Efficacy of Osimertinib With or Without Chemotherapy in Epidermal Growth Factor Receptor-Mutated Advanced Non-Small-Cell Lung Cancer
Jänne, Pasi A, Planchard, David, Kobayashi, Kunihiko, Cheng, Ying, Lee, Chee Khoon, Valdiviezo, Natalia, Laktionov, Konstantin, Yang, Tsung-Ying, Yu, Yan, Kato, Terufumi, Jiang, Liyan, Chewaskulyong, Busyamas, Lucien Geater, Sarayut, Maurel, Jean-Marc, Rojas, Carlos, Takahashi, Toshiaki, Havel, Libor, Shepherd, Frances A, Tanaka, Kentaro, Ghiorghiu, Dana, Amin, Neha P, Armenteros-Monterroso, Elena, Huang, Xiangning, Chaudhry, Ammar Ahmed, Yang, James Chih-Hsin
Published in Journal of clinical oncology (01.03.2024)
Published in Journal of clinical oncology (01.03.2024)
Get full text
Journal Article
ADAGIO: A phase IIb, open-label, single-arm, multicenter study assessing the efficacy and safety of adavosertib (AZD1775) as treatment for recurrent or persistent uterine serous carcinoma (039)
Liu, Joyce, Colombo, Nicoletta, Oza, Amit, Frenel, Jean-Sebastien, Corr, Bradley, Rubinstein, Maria, Nevadunsky, Nicole, Lheureux, Stephanie, Gaba, Lydia, Cortijo, Lucía González, Salutari, Vanda, You, Benoit, de Giorgio-Miller, Victoria, Khatun, Mahmuda, Ghiorghiu, Dana, Oaknin, Ana
Published in Gynecologic oncology (01.09.2023)
Published in Gynecologic oncology (01.09.2023)
Get full text
Journal Article
ADAGIO: A phase IIb, open-label, single-arm, multicenter study assessing the efficacy and safety of adavosertib (AZD1775) as treatment for recurrent or persistent uterine serous carcinoma
Liu, Joyce F., Colombo, Nicoletta, Oza, Amit M., Oaknin, Ana, Gaba, Lydia, Frenel, Jean-Sebastien, Nevadunsky, Nicole, de Giorgio-Miller, Victoria, Ni, Pingping, Ghiorghiu, Dana C.
Published in Journal of clinical oncology (20.05.2021)
Published in Journal of clinical oncology (20.05.2021)
Get full text
Journal Article
A phase III, randomized, open label, multicenter, global study of first-line (1L) durvalumab in combination with standard of care (SOC) chemotherapy and durvalumab in combination with tremelimumab and SOC chemotherapy versus SOC chemotherapy alone in patients with unresectable locally advanced or metastatic urothelial cancer (UC)
Galsky, Matt D., Necchi, Andrea, Sridhar, Srikala S., Ogawa, Osamu, Angra, Natasha, Hois, Stephan, He, Philip, Ghiorghiu, Dana C., Bellmunt, Joaquim
Published in Journal of clinical oncology (20.05.2019)
Published in Journal of clinical oncology (20.05.2019)
Get full text
Journal Article
PR072/#1519 Effort: clinical and molecular features associated with clinical benefit from adavosertib with or without olaparib in recurrent ovarian cancer following progression on PARP inhibition (NCT03579316)
Adjei, Naomi, Coleman, Robert, Fellman, Bryan, Tran, Sarah, Yuan, Ying, Ozmen, Tugba Yildiran, Ozmen, Furkan, Sood, Anil, Soliman, Pamela, Wright, Alexi A, Horowitz, Neil, Campos, Susana, Konstantinopoulos, Panagiotis, Gershenson, David, Lu, Karen, Patel, Ami, Ruben, Charnelle, Rabbitt, Alexis, Ottesen, Lone, Ghiorghiu, Dana, Godin, Robert, Liu, Joyce, Mills, Gordon, Westin, Shannon
Published in International journal of gynecological cancer (07.11.2023)
Published in International journal of gynecological cancer (07.11.2023)
Get full text
Journal Article
SELECT-3: a phase I study of selumetinib in combination with platinum-doublet chemotherapy for advanced NSCLC in the first-line setting
Greystoke, Alastair, Steele, Nicola, Arkenau, Hendrik-Tobias, Blackhall, Fiona, Md Haris, Noor, Lindsay, Colin R, Califano, Raffaele, Voskoboynik, Mark, Summers, Yvonne, So, Karen, Ghiorghiu, Dana, Dymond, Angela W, Hossack, Stuart, Plummer, Ruth, Dean, Emma
Published in British journal of cancer (26.09.2017)
Published in British journal of cancer (26.09.2017)
Get full text
Journal Article
POLO: Radiologic assessment of the impact of maintenance olaparib in patients (pts) with metastatic pancreatic cancer (mPaC)
Schwartz, Lawrence Howard, Kindler, Hedy L., Hammel, Pascal, Reni, Michele, Van Cutsem, Eric, Macarulla, Teresa, Hall, Michael J., Park, Joon Oh, Hochhauser, Daniel, Arnold, Dirk, Oh, Do-Youn, Reinacher-Schick, Anke C., Tortora, Giampaolo, Algül, Hana, O'Reilly, Eileen Mary, Fromageau, Jeremie, Ghiorghiu, Dana C., McGuinness, David, Locker, Gershon Y., Golan, Talia
Published in Journal of clinical oncology (20.01.2021)
Published in Journal of clinical oncology (20.01.2021)
Get full text
Journal Article
Abstract LB277: Exposure response and safety analysis of osimertinib in combination with pemetrexed and platinum-based chemotherapy for the first-line treatment of locally advanced or metastatic NSCLC patients with EGFRm (FLAURA2)
Yang, Jincheng, Olabode, Damilola, Sawant, Aarti, Vishwanathan, Karthick, Bachina, Srinivas, Todd, Alexandar, Ghiorghiu, Dana, Rukazenkov, Yuri, Phipps, Alex, Zhou, Diansong, Shahraz, Azar
Published in Cancer research (Chicago, Ill.) (05.04.2024)
Published in Cancer research (Chicago, Ill.) (05.04.2024)
Get full text
Journal Article
Abstract 4897: Detection of MET-mediated EGFR tyrosine kinase inhibitor (TKI) resistance in advanced non-small cell lung cancer (NSCLC): biomarker analysis of the TATTON study
Hartmaier, Ryan J., Han, Ji-Youn, Cho, Byoung Chul, Frigault, Melanie M., Markovets, Aleksandra, L’Hernault, Anne, Duncan, David, Lao-Sirieix, Pierre, Barrett, J. Carl, Verheijen, Remy B., Ghiorghiu, Dana, Wessen, Jonathan, Oxnard, Geoffrey R.
Published in Cancer research (Chicago, Ill.) (01.07.2019)
Published in Cancer research (Chicago, Ill.) (01.07.2019)
Get full text
Journal Article